Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04610827 · ClinicalTrials.gov registry record · Phase 4
Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder
A Phase 4 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT04610827: Clinical Trial Phase 4 study, sponsored by Mayo Clinic.
NCT04610827 is a Phase 4 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04610827, a Phase 4 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this research study is to see if the level of serum ferritin differs based on how often oral iron (in the form of ferrous sulfate) is given to children with restless leg syndrome/periodic limb movement disorder.
Interventions
- DRUG Ferrous sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-11-16 |
| Est. Completion | 2021-06-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04610827
The ClinicalTrials.gov registry entry for NCT04610827 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ferrous sulfate is the first listed.
NCT04610827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04610827 about?
NCT04610827 is a clinical study titled "Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder". The purpose of this research study is to see if the level of serum ferritin differs based on how often oral iron (in the form of ferrous sulfate) is given to children with restless leg syndrome/periodic limb movement disorder.
What is the current status of trial NCT04610827?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2020-11-16. Estimated completion is 2021-06-29.
What interventions are being tested in trial NCT04610827?
The interventions under investigation include: Ferrous sulfate (DRUG).
Who is sponsoring clinical trial NCT04610827?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.